Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Defining the hidden burden of disease in rural communities in Bangladesh, Cambodia and Thailand: a cross-sectional household health survey protocol

Zhang M. et al, (2024), BMJ Open, 14, e081079 - e081079

BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection

Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347

Prevalence and Risk Factors of Neonatal Hyperbilirubinemia in a Semi-Rural Area of the Democratic Republic of Congo: A Cohort Study

Fanello C. et al, (2023), The American Journal of Tropical Medicine and Hygiene, 109, 965 - 974

Pharmacokinetics of single low dose primaquine in Ugandan and Congolese children with falciparum malaria

Mukaka M. et al, (2023), eBioMedicine, 96, 104805 - 104805

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency

Taylor WRJ. et al, (2023), PLOS Neglected Tropical Diseases, 17, e0011522 - e0011522

The heterogeneity of symptom reporting across study sites: a secondary analysis of a randomised placebo-controlled multicentre antimalarial trial

Thriemer K. et al, (2023), BMC Medical Research Methodology, 23

BurkHostGEN: a study protocol for evaluating variations in the Burkholderia pseudomallei and host genomes associated with melioidosis infection

Angchagun K. et al, (2023), Wellcome Open Research, 8, 347 - 347

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance

Mo Y. et al, (2023), Wellcome Open Research, 8, 179 - 179

Fever and health-seeking behaviour among migrants living along the Thai-Myanmar border: a mixed-methods study.

Khirikoekkong N. et al, (2023), BMC infectious diseases, 23

Experiences, coping strategies and perspectives of people in Malaysia during the COVID-19 pandemic.

Cheah PK. et al, (2023), BMC public health, 23

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance

Mo Y. et al, (2023), Wellcome Open Research, 8, 179 - 179

Safety of age-dosed, single low-dose primaquine in children with glucose-6-phosphate dehydrogenase deficiency who are infected with Plasmodium falciparum in Uganda and the Democratic Republic of the Congo: a randomised, double-blind, placebo-controlled, non-inferiority trial

Taylor WR. et al, (2023), The Lancet Infectious Diseases, 23, 471 - 483

Investigating the Secondary Use of Clinical Research Data: Protocol for a Mixed Methods Study

Waithira N. et al, (2023), JMIR Research Protocols, 12, e44875 - e44875

Intravenous Doxycycline, Azithromycin, or Both for Severe Scrub Typhus

Varghese GM. et al, (2023), New England Journal of Medicine, 388, 792 - 803

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance.

Mo Y. et al, (2023), Wellcome open research, 8

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Tripura R. et al, (2023), The Lancet Infectious Diseases, 23, 81 - 90

A Clinically Oriented antimicrobial Resistance surveillance Network (ACORN): pilot implementation in three countries in Southeast Asia, 2019-2020

van Doorn HR. et al, (2022), Wellcome Open Research, 7, 309 - 309

Investigating the Secondary Use of Clinical Research Data: Protocol for a Mixed Methods Study (Preprint)

Waithira N. et al, (2022)

Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited Settings

Chandna A. et al, (2022), Clinical Infectious Diseases, 75, e368 - e379

Triple therapy with artemether–lumefantrine plus amodiaquine versus artemether–lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial

Peto TJ. et al, (2022), The Lancet Infectious Diseases, 22, 867 - 878

Load More

Include forthcoming?